You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lncRNA NBR2

Showing 1 - 25 of 101
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

lncRNA NBR2 Regulating Endothelial Pyroptosis by Targeting GSDMD

Recruiting
  • Sepsis
  • the levels of pyroptosis
  • Nanjing, Jiangsu, China
    Zhongda Hospital, School of Medicine, Southeast University
Jun 9, 2020

Role of LncRNA H19 in The Regulation of IGF-1R Expression

Completed
  • Hepatocellular Carcinoma
  • +2 more
  • Blood sample collection
  • Mansoura, Dakahliya, Egypt
  • +1 more
Apr 5, 2022

lncRNA NEAT1 in Alleviating Acute Respiratory Distress Syndrome

Enrolling by invitation
  • Acute Respiratory Distress Syndrome
  • Inflammation
  • no intervention
  • Beijing, Beijing, China
    Department of Respiratory and Critical Care Medicine, Beijing An
Jun 16, 2021

Long Non-coding RNA SNHG15 asNovel Biomarker in HBV Associated

Not yet recruiting
  • HCC
  • No intervention was required for patients or control group in this study
  • (no location specified)
Apr 21, 2023

Chronicization of Radiation-induced Acute Intestinal Injury

Not yet recruiting
  • Radiation-induced Intestinal Injury
  • NCRT+TME
  • (no location specified)
Feb 19, 2023

lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially

Completed
  • Potentially Malignant Lesions, Oral Lichen Planus, Leukoplakia
  • Real-time Polymerase Chain Reaction technique
  • Fayoum, Egypt
    Fayoum University
Feb 7, 2023

Circulating lncRNAs on Type 2 Diabetic Peripheral Neuropathy

Recruiting
  • Diabetic Peripheral Neuropathy
  • lncRNA detection
  • Shanghai, Shanghai, China
    Jinshan Hospital Affiliated to Fudan University
Nov 26, 2020

Peripheral Blood Non-coding RNAs as Diagnosis and Prognosis

Completed
  • Acute Pancreatitis
    • Linyi, Shandong, China
    • +2 more
    Oct 17, 2022

    lncRNA-based Nomogram to Assist Childhood Asthma Diagnosis

    Not yet recruiting
    • Childhood Asthma
      • (no location specified)
      Aug 2, 2021

      Advanced Gastric Carcinoma, Immunotherapy Trial in Beijing (Circulating exosomal lncRNA-GC1 detection)

      Completed
      • Advanced Gastric Carcinoma
      • Immunotherapy
      • Circulating exosomal lncRNA-GC1 detection
      • Beijing, Beijing, China
        Chinese PLA General Hospital
      Oct 7, 2022

      Autophagy-related Genes ,LncRNA and SNPs With Colorectal Cancer

      Recruiting
      • Colo-rectal Cancer
      • serum HOTTIP ,EIF4EBP1 and serum SNP HOTTIP rs1859168
      • Assiut, Egypt
        Assiut University
      Aug 18, 2022

      Neo-adjuvant Chemotherapy Evluation in Gastric Cancer Patients

      Recruiting
      • Gastric Cancer
      • Chemotherapy Effect
      • Detection of levels of circulating EV-derived lncRNA-GC1
      • Beijing, Beijing, China
        Chinese PLA General Hospital Ethics Committee
      Dec 12, 2022

      Acute Stroke, Ischemic Stroke Trial in Nanjing (Sequencing of circRNA/miRNA/lncRNA)

      Recruiting
      • Acute Stroke
      • Ischemic Stroke
      • Sequencing of circRNA/miRNA/lncRNA
      • Nanjing, Jiangsu, China
        Nanjing First Hospital, Nanjing Medical University
      Apr 5, 2022

      Urinary Exosome lncRNAs for Preoperative Diagnosis of Lymphatic

      Not yet recruiting
      • Explore Whether lncRNA-ElNAT1 in Urine Exosomes Can be Used as a New Target for Preoperative Diagnosis of Lymph Node Metastasis
      • no intervention
      • Guangzhou, China
        Sun Yat-sen Memorial Hosptial
      Mar 6, 2022

      Spinal Muscular Atrophy Trial in Praha (Individual physiotherapy (SMA-SOC), Hippotherapy, Therapeutic grooming)

      Recruiting
      • Spinal Muscular Atrophy
      • Individual physiotherapy (SMA-SOC)
      • +2 more
      • Praha, Czechia
        Kamila Řasová
      Sep 13, 2022

      Stroke, Acute, Stroke, Ischemic, Endovascular Treatment Trial in Nanjing (Sequencing of circRNA/lncRNA/miRNA)

      Recruiting
      • Stroke, Acute
      • +2 more
      • Sequencing of circRNA/lncRNA/miRNA
      • Nanjing, Jiangsu, China
        Nanjing First Hospital, Nanjing Medical University
      Apr 5, 2022

      Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)

      Terminated
      Has Results
      • Rheumatoid Arthritis (RA)
      • Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium
      • +29 more
      Aug 18, 2021

      Diabetic Nephropathies Trial in Worldwide (Placebo, BI 685509)

      Completed
      • Diabetic Nephropathies
      • Placebo
      • BI 685509
      • Victorville, California
      • +77 more
      Jan 26, 2023

      The Long Non Coding MALAT1 asPotential Salivary Diagnostic

      Completed
      • Oral Cancer Biomarkers
        • Giza, Egypt
          Rania Hassan Shalby
        Jan 31, 2023

        Diabetes, Type 2 Trial in Worldwide (BI 456906, Placebo, Semaglutide)

        Completed
        • Diabetes Mellitus, Type 2
        • BI 456906
        • +2 more
        • Huntington Park, California
        • +79 more
        Mar 22, 2022

        Diabetes, Type 2 Trial in Worldwide (Metformin DR, Metformin IR, Metformin DR Placebo)

        Recruiting
        • Diabetes Mellitus, Type 2
        • Metformin DR
        • +3 more
        • Glendale, Arizona
        • +86 more
        Jun 7, 2022

        Long Non-coding RNA in Process of Epithelial-mesenchymal

        Active, not recruiting
        • Periodontal Disease, AVDC Stage 3and 4
        • +2 more
        • periodontitis challenge
        • Baghdad, Iraq
          saif mohammed T AL Mufti
        Aug 8, 2023

        Use of Circulating Exosomal LncRNA-GC1 to Monitor Gastric Cancer

        Recruiting
        • Gastric Cancer
        • Measurement of levels of circulating exosomal lncRNA-GC1
        • Beijing, Beijing, China
          Xinxin Wang
        Jun 24, 2022

        Type 2 Diabetes, Renal Impairment Trial in Worldwide (Insulin glargine 300 U/mL, Insulin degludec 100 U/mL)

        Recruiting
        • Type 2 Diabetes Mellitus
        • Renal Impairment
        • Insulin glargine 300 U/mL
        • Insulin degludec 100 U/mL
        • Yuma, Arizona
        • +62 more
        Dec 14, 2022

        Refractive Ametropia Trial (BL-3100-NBR03 multi-purpose solution, renu® Advanced Formula multi-purpose solution)

        Not yet recruiting
        • Refractive Ametropia
        • BL-3100-NBR03 multi-purpose solution
        • renu® Advanced Formula multi-purpose solution
        • (no location specified)
        Sep 30, 2022